Literature DB >> 30103941

Anti-LFA-1 induces CD8 T-cell dependent allograft tolerance and augments suppressor phenotype CD8 cells.

Robert J Plenter1, Todd J Grazia2, Marilyne G Coulombe3, Michelle K Nelsen4, Christine M Lin5, K Scott Beard3, Tinalyn M Kupfer3, Martin R Zamora6, Ronald G Gill3, Biagio A Pietra7.   

Abstract

The induction of tolerance to transplanted organs is a major objective in transplantation immunology research. Lymphocyte function-associated antigen-1 (LFA-1) interactions have been identified as a key component of the T-cell activation process that may be interrupted to lead to allograft tolerance. In mice, αLFA-1 mAb is a potent monotherapy that leads to the induction of donor-specific transferable tolerance. By interrogating important adaptive and innate immunity pathways, we demonstrate that the induction of tolerance relies on CD8+T-cells. We further demonstrate that αLFA-1 induced tolerance is associated with CD8+CD28-T-cells with a suppressor phenotype, and that while CD8 cells are present, the effector T-cell response is abrogated. A recent publication has shown that CD8+CD28- cells are not diminished by cyclosporine or rapamycin, therefore CD8+CD28- cells represent a clinically relevant population. To our knowledge, this is the first time that a mechanism for αLFA-1 induced tolerance has been described.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Rejection; Suppressor cells; Tolerance

Mesh:

Substances:

Year:  2018        PMID: 30103941      PMCID: PMC6174680          DOI: 10.1016/j.cellimm.2018.08.003

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  54 in total

Review 1.  CD8+CD28- T suppressor cells and the induction of antigen-specific, antigen-presenting cell-mediated suppression of Th reactivity.

Authors:  R Cortesini; J LeMaoult; R Ciubotariu; N S Cortesini
Journal:  Immunol Rev       Date:  2001-08       Impact factor: 12.988

2.  CD1-dependent natural killer (NK1.1(+)) T cells are required for oral and portal venous tolerance induction.

Authors:  Julie A Margenthaler; Keith Landeros; Masaaki Kataoka; M Wayne Flye
Journal:  J Surg Res       Date:  2002-05-01       Impact factor: 2.192

3.  CTLA4Ig combined with anti-LFA-1 prolongs cardiac allograft survival indefinitely.

Authors:  Matthias Corbascio; Helene Ekstrand; Cecilia Osterholm; Zhongquan Qi; Mecislovas Simanaitis; Christian P Larsen; Thomas C Pearson; Kristian Riesbeck; Henrik Ekberg
Journal:  Transpl Immunol       Date:  2002-06       Impact factor: 1.708

Review 4.  Generation and function of antigen-specific suppressor and regulatory T cells.

Authors:  Nicole Suciu-Foca; John S Manavalan; Raffaello Cortesini
Journal:  Transpl Immunol       Date:  2003 Jul-Sep       Impact factor: 1.708

5.  A major role for host MHC class I antigen presentation for promoting islet allograft survival.

Authors:  J Beilke; Z Johnson; N Kuhl; R G Gill
Journal:  Transplant Proc       Date:  2004-05       Impact factor: 1.066

6.  Critical role of donor tissue expression of programmed death ligand-1 in regulating cardiac allograft rejection and vasculopathy.

Authors:  Jun Yang; Joyce Popoola; Shakila Khandwala; Nidyanandh Vadivel; Vijay Vanguri; Xueli Yuan; Shirine Dada; Indira Guleria; Chaorui Tian; M Javeed Ansari; Tahiro Shin; Hideo Yagita; Miyuki Azuma; Mohamed H Sayegh; Anil Chandraker
Journal:  Circulation       Date:  2008-01-22       Impact factor: 29.690

7.  Spontaneous allograft tolerance in B7-deficient mice independent of preexisting endogenous CD4+CD25+ regulatory T-cells.

Authors:  Todd J Grazia; Robert J Plenter; An N Doan; Brian P Kelly; Sarah M Weber; Jonathan S Kurche; Susan O Cushing; Ronald G Gill; Biagio A Pietra
Journal:  Transplantation       Date:  2007-06-15       Impact factor: 4.939

8.  LFA-1 blockade induces effector and regulatory T-cell enrichment in lymph nodes and synergizes with CTLA-4Ig to inhibit effector function.

Authors:  Natalie M Reisman; Tamara L Floyd; Maylene E Wagener; Allan D Kirk; Christian P Larsen; Mandy L Ford
Journal:  Blood       Date:  2011-10-04       Impact factor: 22.113

9.  Blockade of CD11a by efalizumab in psoriasis patients induces a unique state of T-cell hyporesponsiveness.

Authors:  Emma Guttman-Yassky; Yulia Vugmeyster; Michelle A Lowes; Francesca Chamian; Toyoko Kikuchi; Mark Kagen; Patricia Gilleaudeau; Edmund Lee; Brisdell Hunte; Kathy Howell; Wolfgang Dummer; Sarah C Bodary; James G Krueger
Journal:  J Invest Dermatol       Date:  2008-01-31       Impact factor: 8.551

10.  NK cells promote transplant tolerance by killing donor antigen-presenting cells.

Authors:  Guang Yu; Xuemin Xu; Minh Diem Vu; Elizabeth D Kilpatrick; Xian Chang Li
Journal:  J Exp Med       Date:  2006-07-24       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.